CCT239065

CCT239065 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

CCT239065 is a mutant protein kinase inhibitor that inhibits signaling downstream of V600EBRAF in cancer cells, blocking DNA synthesis, and inhibiting proliferation.

CCT239065 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

CCT239065 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
J & K SCIENTIFIC LTD.	010-82848833 400-666-7788	jkinfo@jkchemical.com	China	96815	76
NCE Biomedical Co.,Ltd.	4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988		China	1494	55
AdooQ BioScience, LLC	+1 (866) 930-6790	info@adooq.com	United States	2784	58
Shanghai TaoSu Biochemical Technology Co., Ltd.	021-33632979	info@tsbiochem.com	China	8072	58
LETOPHARM LIMITED	+86-21-5821 5861	sales@letopharm.com	China	2384	58
SPIRO PHARMA		eric_feng1954@126.com	China	9254	55
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226	sales@rrkchem.com	China	56086	58
Absin Bioscience Inc.	021-38015121 15000105423	wulan@absin.cn	China	24734	58
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44843	58
Changzhou Furuisi Biotechnology Co., Ltd	0519-85524369	3477467573@qq.com	China	8618	58

---

• CCT239065
• Urea, N-[4-[(3,4-dihydro-3-oxopyrido[2,3-b]pyrazin-8-yl)oxy]-2-(methylthio)phenyl]-N'-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-
• 1163719-51-4
• Aromatics, Heterocycles, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals